文献速递乳腺癌放疗放疗物理与技术

深吸气屏气在右侧乳腺癌放疗中降低危及器官剂量:一项治疗计划研究

Dose reduction to organs at risk with deep-inspiration breath-hold during right breast radiotherapy: a treatment planning study.
PubMed 文献 · Radiat Oncol · 2019-12-10

本研究基于20例曾接受左侧乳腺癌放疗患者的自由呼吸与深吸气屏气CT数据集,回顾性制定右侧全乳及区域淋巴结照射计划。结果显示深吸气屏气可增加总肺体积,在联合区域淋巴结照射时显著降低同侧肺平均剂量、V20Gy及右冠状动脉最大剂量,并减少肝脏V20Gy和最大剂量。

要点

  • 深吸气屏气在右侧乳腺癌联合区域淋巴结照射时可降低同侧肺平均剂量与V20Gy。
  • 深吸气屏气显著降低右侧乳腺癌区域淋巴结照射时右冠状动脉最大剂量。
  • 深吸气屏气在所有队列中均降低肝脏V20Gy和最大剂量。

核心结论

  • 深吸气屏气是右侧乳腺癌放疗中有前景的方法,可显著保护正常组织,尤其在同时照射同侧内乳淋巴结时。

研究设计与样本

  • 治疗计划研究,获取20例既往左侧乳腺癌放疗患者的自由呼吸和深吸气屏气CT数据集。
  • 记录临床靶区、肺、心脏、左前降支动脉、右冠状动脉和肝脏的剂量体积指标,采用Wilcoxon符号秩检验比较自由呼吸与深吸气屏气计划差异,P<0.05为有统计学意义。

主要发现

  • 深吸气屏气较自由呼吸增加单纯全乳和全乳加区域淋巴结队列的平均总肺体积(P=0.001)。
  • 单纯全乳组中,自由呼吸与深吸气屏气之间同侧肺任何剂量体积指标均无显著改善。
  • 全乳加区域淋巴结组中,同侧肺平均剂量从18.9±3.2 Gy降至15.9±2.3 Gy(P=0.002),V20Gy从45.3±13.3%降至32.9±9.4%(P=0.002)。
  • 区域淋巴结照射中,深吸气屏气显著降低右冠状动脉最大剂量(11.6±7.2 Gy降至5.6±2.9 Gy,P=0.03)。
  • 所有队列中,深吸气屏气较自由呼吸均显著降低肝脏V20Gy和最大剂量。

临床怎么用

  • 对右侧乳腺癌需联合区域淋巴结照射(尤其含内乳淋巴结)的患者,可考虑采用深吸气屏气以降低同侧肺和右冠状动脉剂量。
  • 单纯右侧全乳照射时,深吸气屏气对同侧肺剂量体积指标无明显改善,但仍可降低肝脏剂量。

局限性

  • 本研究为回顾性治疗计划研究,样本量较小(共20例),且基于既往左侧乳腺癌患者的CT数据集进行右侧计划模拟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The addition of regional nodal radiation (RNI) to whole breast irradiation for high risk breast cancer improves metastases free survival and new data suggests it contributes additional benefit to overall survival. Deep inspiration breath hold (DIBH) has been shown to reduce cardiac and pulmonary dose in the context of left-sided disease treated with or without RNI, yet few studies have investigated its utility for right-breast cancer. This study investigates the potential advantages of DIBH in local and locoregional radiotherapy for right-sided breast cancer. METHODS: Free-breathing (FB) and DIBH computed tomography datasets were obtained from twenty patients who previously underwent radiotherapy for left-sided breast cancer. Ten patients were retrospectively planned for whole right breast only irradiation and ten patients were planned for irradiation to the whole breast plus ipsilateral supra-clavicular (SC) nodes, with and without irradiation of the ipsilateral internal mammary nodes (IMN). Dose-volume metrics for the clinical target volume, lungs, heart, left anterior descending artery, right coronary artery (RCA) and liver were recorded. Differences between FB and DIBH plans were analysed using Wilcoxon signed-rank tests, with P < 0.05 considered statistically significant. RESULTS: DIBH increased the average total lung volume compared to FB in both breast only and breast plus RNI cohorts (P = 0.001). For the breast only group, there was no significant improvement in any ipsilateral lung dose-volume metric between FB and DIBH. However, for the breast plus RNI group, there was an improvement in ipsilateral lung mean dose (18.9 ± 3.2 Gy to 15.9 ± 2.3 Gy, P = 0.002) and V20Gy (45.3 ± 13.3% to 32.9 ± 9.4%, P = 0.002). In addition, DIBH significantly reduced the maximum dose to the RCA for RNI (11.6 ± 7.2 Gy to 5.6 ± 2.9 Gy, P = 0.03). Significant reductions in the liver V20Gy and maximum dose were observed in all cohorts during DIBH compared to FB. CONCLUSIONS: DIBH is a promising approach for right-breast radiotherapy with considerable sparing of normal tissue, particularly when the ipsilateral IMNs are also irradiated.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Pandeli C, Smyth LML, David S, et al. Dose reduction to organs at risk with deep-inspiration breath-hold during right breast radiotherapy: a treatment planning study. Radiat Oncol. 2019. PMID: 31822293. doi:10.1186/s13014-019-1430-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。